top of page
GettyImages-2179903047_V.jpg

Board of Directors

Pekka Simula

Pekka Simula

Chairman of the Board

Pekka Simula (MsC) is a Partner of Innovestor Life Science VC Fund. He has over 20 years of hands-on management experience in health and life sciences, including founding CEO of Oncos Therapeutics and CEO of Herantis Pharma. Pekka is well-connected in European Life Sciences Industry and a board member of Finnish Bioindustries and mentor and board member in Finnish startup companies in healthcare and life sciences.

Matthias Weber

Matthias Weber

Matthias Weber has over 25 years of experience in the medical devices and diagnostics field. Previously President of Leica Biosystems (part of Danaher) and VP at GE Healthcare. Medical doctor by training with professional experience in cardiology.

Tom Fleming

Tom Fleming

Tom Fleming has over 25 years in medical device and 10 years of structural heart leadership from clinical through commercial. Previously VP and GM of Boston Scientific Structural Heart.

hardip

Hardip Thakerar 

Hardip is a recognized global leader in structural heart and cardiovascular medicine, bringing over 20 years of experience from senior roles at Boston Scientific and Medtronic. She has been instrumental in the development and adoption of groundbreaking procedures such as TAVI, TMVR, tricuspid valve repair, and leaflet modification, with a keen understanding of heart failure therapies. Hardip has advised several successful startups and is widely respected for her strategic vision, extensive KOL network, and track record of driving innovation in next-generation medical devices.

Olli Keränen

Olli Keränen

Clinical background and 30+ years in biotech and medtech product and business development.

HVR Cardio logo

HVR Cardio Oy

Upseerinkatu 1, Tower 1

02600 Espoo, Finland

HVR Cardio US Inc.

14530 Martin Drive

Suite 100

Eden Prairie, MN 55344

LinkedIn logo

CAUTION: Investigational device. Limited by Federal (United States) law to investigational use only. CathHELIX™ is not commercially available and is intended for investigational use only. Performance specifications and claims are subject to revision pending completion of regulatory approvals. CathHELIX™ is a trademark of HVR Cardio Oy.

 

© 2025 HVR Cardio Oy. All rights reserved.

bottom of page